{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:13:15Z","timestamp":1793679195650,"version":"4.5.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20354"],"award-info":[{"award-number":["U20A20354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["Z201100005520017"],"award-info":[{"award-number":["Z201100005520017"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["Z201100005520016"],"award-info":[{"award-number":["Z201100005520016"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012149","name":"National Key Scientific Instrument and Equipment Development Projects of China","doi-asserted-by":"publisher","award":["81530036"],"award-info":[{"award-number":["81530036"]}],"id":[{"id":"10.13039\/501100012149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012149","name":"National Key Scientific Instrument and Equipment Development Projects of China","doi-asserted-by":"publisher","award":["31627803"],"award-info":[{"award-number":["31627803"]}],"id":[{"id":"10.13039\/501100012149","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tjpad.2026.100514","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:42:34Z","timestamp":1772224954000},"page":"100514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic and prognostic utility of serum \u03b2-synuclein in Alzheimer\u2019s disease: a longitudinal cohort study"],"prefix":"10.1016","volume":"13","author":[{"given":"Siqi","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4624-0336","authenticated-orcid":false,"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2026.100514_bib0001","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.tjpad.2026.100514_bib0002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100514_bib0003","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jalz.2019.05.006","article-title":"Frequency and longitudinal clinical outcomes of Alzheimer\u2019s AT(N) biomarker profiles: a longitudinal study","volume":"15","author":"Yu","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100514_bib0004","article-title":"Discriminative accuracy of the A\/T\/N scheme to identify cognitive impairment due to Alzheimer\u2019s disease","volume":"15","author":"Pascoal","year":"2023","journal-title":"Alzheimers Dement Diagn Assess Amp Dis Monit"},{"key":"10.1016\/j.tjpad.2026.100514_bib0005","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1007\/s00415-024-12221-7","article-title":"Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohort","volume":"271","author":"Canu","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.tjpad.2026.100514_bib0006","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41380-024-02709-z","article-title":"Alzheimer\u2019s disease biomarkers and their current use in clinical research and practice","volume":"30","author":"Hunter","year":"2025","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.tjpad.2026.100514_bib0007","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100514_bib0008","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-024-02988-7","article-title":"Revised criteria for the diagnosis and staging of Alzheimer\u2019s disease","volume":"30","author":"Jack","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2026.100514_bib0009","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pharmthera.2018.11.006","article-title":"Synaptic dysfunction in Alzheimer\u2019s disease: mechanisms and therapeutic strategies","volume":"195","author":"Chen","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.tjpad.2026.100514_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Spires-Jones TL. Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.tjpad.2026.100514_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","article-title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease","volume":"12","author":"Colom-Cadena","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2026.100514_bib0012","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/alz.12097","article-title":"In vivo measurement of widespread synaptic loss in Alzheimer\u2019s disease with SV2A PET","volume":"16","author":"Mecca","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100514_bib0013","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13195-022-01125-1","article-title":"\u03b2-synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer\u2019s disease","volume":"14","author":"Mohaupt","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2026.100514_bib0014","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/jnnp-2020-324306","article-title":"Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer\u2019s disease","volume":"92","author":"Halbgebauer","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tjpad.2026.100514_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jnnp-2022-329124","article-title":"Cerebrospinal fluid \u03b2-synuclein as a synaptic biomarker for preclinical Alzheimer\u2019s disease","volume":"94","author":"Barba","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tjpad.2026.100514_bib0016","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1002\/alz.13046","article-title":"Blood \u03b2-synuclein is related to amyloid PET positivity in memory clinic patients","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100514_bib0017","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1002\/alz.13103","article-title":"Higher plasma \u03b2-synuclein indicates early synaptic degeneration in Alzheimer\u2019s disease","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100514_bib0018","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10048-011-0311-8","article-title":"New brain-specific beta-synuclein isoforms show expression ratio changes in Lewy body diseases","volume":"13","author":"Beyer","year":"2012","journal-title":"Neurogenetics"},{"key":"10.1016\/j.tjpad.2026.100514_bib0019","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1097\/00001756-200109170-00018","article-title":"Expression of \u03b2-synuclein in normal human astrocytes","volume":"12","author":"Tanji","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.tjpad.2026.100514_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70146","article-title":"Early increase of the synaptic blood marker \u03b2-synuclein in asymptomatic autosomal dominant Alzheimer\u2019s disease","volume":"21","author":"Oeckl","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100514_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2025-336189","article-title":"Serum level changes of the synaptic marker beta-synuclein in Alzheimer\u2019s disease continuum and other dementias","author":"Barba","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tjpad.2026.100514_bib0022","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2026.100514_bib0023","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1021\/acs.jproteome.9b00824","article-title":"Targeted mass spectrometry suggests beta-synuclein as synaptic blood marker in Alzheimer\u2019s disease","volume":"19","author":"Oeckl","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1016\/j.tjpad.2026.100514_bib0024","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1-42) in human cerebrospinal fluid","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"10.1016\/j.tjpad.2026.100514_bib0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaneurol.2019.4749","article-title":"Characterization of Alzheimer disease biomarker discrepancies using cerebrospinal fluid phosphorylated tau and AV1451 positron emission tomography","volume":"77","author":"Meyer","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2026.100514_bib0026","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1073\/pnas.200033797","article-title":"Measuring the thickness of the human cerebral cortex from magnetic resonance images","volume":"97","author":"Fischl","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.tjpad.2026.100514_bib0027","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroimage.2015.11.073","article-title":"MUSE: multi-atlas region segmentation utilizing ensembles of registration algorithms and parameters, and locally optimal atlas selection","volume":"127","author":"Doshi","year":"2016","journal-title":"NeuroImage"},{"key":"10.1016\/j.tjpad.2026.100514_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117129","article-title":"Longitudinal ComBat: a method for harmonizing longitudinal multi-scanner imaging data","volume":"220","author":"Beer","year":"2020","journal-title":"NeuroImage"},{"key":"10.1016\/j.tjpad.2026.100514_bib0029","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical Alzheimer cognitive composite","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2026.100514_bib0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","article-title":"Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","volume":"6","author":"Crane","year":"2012","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.tjpad.2026.100514_bib0031","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","article-title":"Increased CSF neurogranin concentration is specific to Alzheimer disease","volume":"86","author":"Wellington","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2026.100514_bib0032","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaneurol.2015.1867","article-title":"Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease","volume":"72","author":"Kester","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2026.100514_bib0033","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1093\/brain\/awv267","article-title":"Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer\u2019s disease","volume":"138","author":"Portelius","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2026.100514_bib0034","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/WNL.0000000000004569","article-title":"Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers","volume":"89","author":"Casaletto","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2026.100514_bib0035","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/emmm.201606540","article-title":"Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer\u2019s disease","volume":"8","author":"Mattsson","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.tjpad.2026.100514_bib0036","first-page":"8","article-title":"Tau association with synaptic vesicles causes presynaptic dysfunction","author":"Zhou","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.tjpad.2026.100514_bib0037","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2016.03.044","article-title":"Tau pathology-mediated presynaptic dysfunction","volume":"325","author":"Moreno","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.tjpad.2026.100514_bib0038","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-017-0169-9","article-title":"Soluble oligomeric amyloid-\u03b2 induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain","volume":"12","author":"Arbel-Ornath","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.tjpad.2026.100514_bib0039","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1073\/pnas.1206171109","article-title":"Critical role of soluble amyloid-\u03b2 for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease","volume":"109","author":"Busche","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.tjpad.2026.100514_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/alzrt164","article-title":"Biomarkers for Alzheimer\u2019s disease in plasma, serum and blood - conceptual and practical problems","volume":"5","author":"Galasko","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2026.100514_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00345","article-title":"The past and the future of Alzheimer\u2019s disease CSF biomarkers\u2014a journey toward validated biochemical tests covering the whole spectrum of molecular events","volume":"9","author":"Blennow","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.tjpad.2026.100514_bib0042","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/mds.28941","article-title":"Alpha and beta synucleins: from pathophysiology to clinical application as biomarkers","volume":"37","author":"Barba","year":"2022","journal-title":"Mov Disord"},{"key":"10.1016\/j.tjpad.2026.100514_bib0043","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jalz.2015.12.005","article-title":"Meta-analysis of synaptic pathology in Alzheimer\u2019s disease reveals selective molecular vesicular machinery vulnerability","volume":"12","author":"de Wilde","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100514_bib0044","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12790","article-title":"Relationship of serum beta-synuclein with blood biomarkers and brain atrophy","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100514_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-015-0013-z","article-title":"Synaptic dysfunction and septin protein family members in neurodegenerative diseases","volume":"10","author":"Marttinen","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.tjpad.2026.100514_bib0046","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41573-023-00823-1","article-title":"Targeting synapse function and loss for treatment of neurodegenerative diseases","volume":"23","author":"Dejanovic","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.tjpad.2026.100514_bib0047","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.tjpad.2026.100514_bib0048","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JAD-231034","article-title":"A meta-analysis on presynaptic changes in Alzheimer\u2019s disease","volume":"97","author":"Anschuetz","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2026.100514_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00735","article-title":"Targeting the synapse in Alzheimer\u2019s disease","volume":"13","author":"Jackson","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.tjpad.2026.100514_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2023.1129036","article-title":"Alzheimer\u2019s disease as a synaptopathy: evidence for dysfunction of synapses during disease progression","volume":"15","author":"Meftah","year":"2023","journal-title":"Front Synaptic Neurosci"},{"key":"10.1016\/j.tjpad.2026.100514_bib0051","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1212\/WNL.0000000000200002","article-title":"Blood \u03b2-synuclein and neurofilament light chain during the course of prion disease","volume":"98","author":"Halbgebauer","year":"2022","journal-title":"Neurology"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:03:02Z","timestamp":1777629782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2274580726000385"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100514","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and prognostic utility of serum \u03b2-synuclein in Alzheimer\u2019s disease: a longitudinal cohort study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100514"}}